Simvastatin attenuates rhinovirus-induced interferon and CXCL10 secretion from monocytic cells in vitro

Journal of Leukocyte Biology

Volumn 95, Issue 6, 2014, Pages 951-959

  Wickert, Lisa E ^a   Karta, Maya R ^a   Audhya, Anjon ^a   Gern, James E ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chemokines; Inflammation; Macrophages; Statins; Virus

Indexed keywords

ALPHA INTERFERON; CHOLESTEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; SIMVASTATIN; STAT1 PROTEIN;

ARTICLE; ASTHMA; CELL SURFACE; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DONOR; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RHINOVIRUS; RHINOVIRUS INFECTION; STIMULATION;

CHEMOKINES; INFLAMMATION; MACROPHAGES; STATINS; VIRUS;

CHEMOKINE CXCL10; HELA CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERFERON-ALPHA; MONOCYTES; RHINOVIRUS; SIMVASTATIN; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84901702729     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0713413     Document Type: Article

References (48)

1. Gavala, M. L., Bertics, P. J., Gern, J. E. (2011) Rhinoviruses, allergic inflammation, and asthma. Immunol. Rev. 242, 69-90.
2. Jackson, D. J., Johnston, S. L. (2010) The role of viruses in acute exacerbations of asthma. J. Allergy Clin. Immunol. 125, 1178-1187.
3. Proud, D., Sanders, S. P., Wiehler, S. (2004) Human rhinovirus infection induces airway epithelial cell production of human β-defensin 2 both in vitro and in vivo. J. Immunol. 172, 4637-4645.
4. Bentley, J. K., Sajjan, U. S., Dzaman, M. B., Jarjour, N. N., Lee, W. M., Gern, J. E., Hershenson, M. B. (2013) Rhinovirus colocalizes with CD68-and CD11b-positive macrophages following experimental infection in humans. J. Allergy Clin. Immunol. 132, 758. e3-761. e3.
5. Korpi-Steiner, N. L., Valkenaar, S. M., Bates, M. E., Evans, M. D., Gern, J. E., Bertics, P. J. (2010) Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin. Exp. Allergy 40, 1203-1213.
6. Smith, D. L., DeShazo, R. D. (1992) Integrins, macrophages, and sarcoidosis. Chest 102, 659-660.
7. Korpi-Steiner, N. L., Bates, M. E., Lee, W. M., Hall, D. J., Bertics, P. J. (2006) Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J. Leukoc. Biol. 80, 1364-1374.
8. Wark, P. A., Bucchieri, F., Johnston, S. L., Gibson, P. G., Hamilton, L., Mimica, J., Zummo, G., Holgate, S. T., Attia, J., Thakkinstian, A., Davies, D. E. (2007) IFN-α-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 120, 586-593.
9. Bu, D. X., Griffin, G., Lichtman, A. H. (2011) Mechanisms for the antiinflammatory effects of statins. Curr. Opin. Lipidol. 22, 165-170.
10. Bjorkhem-Bergman, L., Lindh, J. D., Bergman, P. (2011) What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br. J. Clin. Pharmacol. 72, 164-165.
11. Xu, L., Dong, X. W., Shen, L. L., Li, F. F., Jiang, J. X., Cao, R., Yao, H. Y., Shen, H. J., Sun, Y., Xie, Q. M. (2012) Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma. Int. Immunopharmacol. 12, 556-564.
12. Zeki, A. A., Franzi, L., Last, J., Kenyon, N. J. (2009) Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am. J. Respir. Crit. Care Med. 180, 731-740.
13. Rosch, P. J., McCully, K. (2013) Statin use and reduced cancer-related mortality. N. Engl. J. Med. 368, 576.
14. Janda, S., Park, K., FitzGerald, J. M., Etminan, M., Swiston, J. (2009) Statins in COPD: a systematic review. Chest 136, 734-743.
15. Hothersall, E. J., Chaudhuri, R., McSharry, C., Donnelly, I., Lafferty, J., McMahon, A. D., Weir, C. J., Meiklejohn, J., Sattar, N., McInnes, I., Wood, S., Thomson, N. C. (2008) Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 63, 1070-1075.
16. Huang, C-C., Chan, W-L., Chen, Y-C., Chen, T-J., Chou, K-T., Lin, S-J., Chen, J-W., Leu, H-B. (2011) Statin use in patients with asthma-a nationwide population-based study. Eur. J. Clin. Invest. 41, 507-512.
17. Menzies, D., Nair, A., Meldrum, K. T., Fleming, D., Barnes, M., Lipworth, B. J. (2007) Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J. Allergy Clin. Immunol. 119, 328-335.
18. Cowan, D. C., Cowan, J. O., Palmay, R., Williamson, A., Taylor, D. R. (2010) Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 65, 891-896.
19. (2000) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am. J. Respir. Crit. Care Med. 162, 2341-2351.
20. Sherry, B., Rueckert, R. (1985) Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J. Virol. 53, 137-143.
21. Kelly, E. A., Rodriguez, R. R., Busse, W. W., Jarjour, N. N. (1997) The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am. J. Respir. Crit. Care Med. 156, 1421-1428.
22. Maecker, H. T., Trotter, J. (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69, 1037-1042.
23. Spurrell, J. C., Wiehler, S., Zaheer, R. S., Sanders, S. P., Proud, D. (2005) Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L85-L95.
24. Palmenberg, A. C., Rathe, J. A., Liggett, S. B. (2010) Analysis of the complete genome sequences of human rhinovirus. J. Allergy Clin. Immunol. 125, 1190-1199.
25. Rezaie-Majd, A., Prager, G. W., Bucek, R. A., Schernthaner, G. H., Maca, T., Kress, H. G., Valent, P., Binder, B. R., Minar, E., Baghestanian, M. (2003) Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 23, 397-403.
26. Gouni-Berthold, I., Berthold, H. K., Gylling, H., Hallikainen, M., Giannakidou, E., Stier, S., Ko, Y., Patel, D., Soutar, A. K., Seedorf, U., Mantzoros, C. S., Plat, J., Krone, W. (2008) Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. Atherosclerosis 198, 198-207.
27. Planaguma, A., Pfeffer, M. A., Rubin, G., Croze, R., Uddin, M., Serhan, C. N., Levy, B. D. (2010) Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4. Mucosal Immunol. 3, 270-279.
28. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
29. Sen, G. C. (2001) Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281.
30. Wormald, S., Hilton, D. J. (2004) Inhibitors of cytokine signal transduction. J. Biol. Chem. 279, 821-824.
31. Lee, C. S., Shin, Y. J., Won, C., Lee, Y. S., Park, C. G., Ye, S. K., Chung, M. H. (2009) Simvastatin acts as an inhibitor of interferon γ-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell 33, 107-114.
32. Lilja, J. J., Kivisto, K. T., Neuvonen, P. J. (1998) Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharmacol. Ther. 64, 477-483.
33. Ucar, M., Neuvonen, M., Luurila, H., Dahlqvist, R., Neuvonen, P. J., Mjorndal, T. (2004) Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. Eur. J. Clin. Pharmacol. 59, 879-882.
34. Lee, C. S., Yi, E. H., Lee, J. K., Won, C., Lee, Y. J., Shin, M. K., Yang, Y. M., Chung, M. H., Lee, J. W., Sung, S. H., Ye, S. K. (2013) Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia. Eur. Respir. J. 41, 1147-1156.
35. Skevaki, C. L., Christodoulou, I., Spyridaki, I. S., Tiniakou, I., Georgiou, V., Xepapadaki, P., Kafetzis, D. A., Papadopoulos, N. G. (2009) Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin. Exp. Allergy 39, 1700-1710.
36. Greenwood, J., Steinman, L., Zamvil, S. S. (2006) Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat. Rev. Immunol. 6, 358-370.
37. Amuro, H., Ito, T., Miyamoto, R., Sugimoto, H., Torii, Y., Son, Y., Nakamichi, N., Yamazaki, C., Hoshino, K., Kaisho, T., Ozaki, Y., Inaba, M., Amakawa, R., Fukuhara, S. (2010) Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis Rheum. 62, 2073-2085.
38. Andreakos, E. (2012) Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed. EMBO Mol. Med. 4, 1231-1233.
39. Gavala, M. L., Bashir, H., Gern, J. E. (2013) Virus/allergen interactions in asthma. Curr. Allergy Asthma Rep. 13, 298-307.
40. Miller, E. K., Hernandez, J. Z., Wimmenauer, V., Shepherd, B. E., Hijano, D., Libster, R., Serra, M. E., Bhat, N., Batalle, J. P., Mohamed, Y., Reynaldi, A., Rodriguez, A., Otello, M., Pisapia, N., Bugna, J., Bellabarba, M., Kraft, D., Coviello, S., Ferolla, F. M., Chen, A., London, S. J., Siberry, G. K., Williams, J. V., Polack, F. P. (2012) A mechanistic role for type III IFN-α1 in asthma exacerbations mediated by human rhinoviruses. Am. J. Respir. Crit. Care Med. 185, 508-516.
41. Sykes, A., Edwards, M. R., Macintyre, J., del Rosario, A., Bakhsoliani, E., Trujillo-Torralbo, M. B., Kon, O. M., Mallia, P., McHale, M., Johnston, S. L. (2012) Rhinovirus 16-induced IFN-α and IFN-α are deficient in bronchoalveolar lavage cells in asthmatic patients. J. Allergy Clin. Immunol. 129, 1506. e6-1514. e6.
42. Feng, X., Han, D., Kilaru, B. K., Franek, B. S., Niewold, T. B., Reder, A. T. (2012) Inhibition of interferon-γ responses in multiple sclerosis immune cells associated with high-dose statins. Arch. Neurol. 69, 1303-1309.
43. Jougasaki, M., Ichiki, T., Takenoshita, Y., Setoguchi, M. (2010) Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Br. J. Pharmacol. 159, 1294-1303.
44. Shuai, K., Liu, B. (2003) Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3, 900-911.
45. Cacalano, N. A., Sanden, D., Johnston, J. A. (2001) Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3, 460-465.
46. Delang, L., Paeshuyse, J., Vliegen, I., Leyssen, P., Obeid, S., Durantel, D., Zoulim, F., Op de Beeck, A., Neyts, J. (2009) Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development. Hepatology 50, 6-16.
47. Radigan, K. A., Urich, D., Misharin, A. V., Chiarella, S. E., Soberanes, S., Gonzalez, A., Perlman, H., Wunderink, R. G., Budinger, G. R., Mutlu, G. M. (2012) The effect of rosuvastatin in a murine model of influenza A infection. PLoS One 7, e35788.
48. Kumaki, Y., Morrey, J. D., Barnard, D. L. (2012) Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice. Future Virol. 7, 801-818.